2008
DOI: 10.1001/archopht.126.12.1695
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of Integrin α4β1 (VLA-4) in Dry Eye Disease

Abstract: To study the effect of topical application of very late antigen 4 (VLA-4) small-molecule antagonist (anti-VLA-4 sm) in a mouse model of dry eye disease. Methods: Anti-VLA-4 sm (or control vehicle) was applied topically to mice placed in a controlledenvironment chamber. Corneal fluorescein staining and conjunctival T-cell enumeration were performed in the different treatment groups. Real-time polymerase chain reaction was used to quantify expression of inflammatory cytokines in the cornea and conjunctiva. Resul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
37
1
1

Year Published

2009
2009
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(39 citation statements)
references
References 28 publications
0
37
1
1
Order By: Relevance
“…21,25 These cytokines activate resident APCs and promote the corneal infiltration of additional CD11b þ cells. 26,27 Activated APCs subsequently stimulate an adaptive immune response, as evidenced by the proliferation of CD4 þ T cells in the draining lymphatics. 1,28 Furthermore, APCs prime pathogenic ocular surface-specific CD4 þ T cells (e.g., T helper 17 cells), supporting the theory that DED has an autoimmune component.…”
Section: Discussionmentioning
confidence: 99%
“…21,25 These cytokines activate resident APCs and promote the corneal infiltration of additional CD11b þ cells. 26,27 Activated APCs subsequently stimulate an adaptive immune response, as evidenced by the proliferation of CD4 þ T cells in the draining lymphatics. 1,28 Furthermore, APCs prime pathogenic ocular surface-specific CD4 þ T cells (e.g., T helper 17 cells), supporting the theory that DED has an autoimmune component.…”
Section: Discussionmentioning
confidence: 99%
“…Synthetic peptide antagonists of integrin αvβ3 inhibited retinal neovascularization in a murine model when administered as intraperitonal or periocular injections (Luna et al 1996), inhibition of αv integrins prevented basic fibroblast growth factor-induced neovascularization of cornea (Klotz et al 2000), and inhibition of α5β1 inhibited and regressed corneal neovascularization after alkali-burns (Muether et al 2007). Blockade of α4β1 decreased dry eye symptoms and inflammation significantly (Ecoiffier et al 2008). Furthermore, integrin signaling and integrin-linked kinase activity could affect the organization and contractility of actin cytoskeleton in trabecular meshwork cells (Faralli et al 2011), a factor known to modulate aqueous humor outflow.…”
Section: Established Functions Of Integrins In the Eye And Their Assomentioning
confidence: 99%
“…CD4 + T cells make a prominent contribution to chronic inflammation during the immunopathogenesis of dry eye, underscoring its basis as an autoimmune-based inflammatory disease. This notion is supported by several lines of evidence: 1) activated CD4 + T cells are localized within the ocular surface tissues of dry eye patients (5,6); 2) CD4 + T cells are sufficient to induce dry eye in mice (4); and 3) compounds that inhibit T cells (e.g., cyclosporine A) attenuate dry eye disease in both animals and humans (5,7). Dry eye disease, induced in a mouse model of autoimmune lacrimal keratoconjunctivitis (ALKC), is a valuable tool for defining the underlying mechanisms of CD4 + T cell-mediated disease (4).…”
mentioning
confidence: 92%